Abstract:Introduction: Serotonin is involved in a variety of physiological functions and brain disorders. In this context, efforts have been made to investigate the in vivo fluctuations of this neurotransmitter using positron emission tomography (PET) imaging paradigms. Since serotonin is a full agonist, it binds preferentially to G-protein coupled receptors. In contrast, antagonist PET ligands additionally interact with uncoupled receptors. This could explain the lack of sensitivity to serotonin fluctuations of current 5-HT1A radiopharmaceuticals which are mainly antagonists and suggests that agonist radiotracers would be more appropriate to measure changes in neurotransmitter release. The present study evaluated the sensitivity to endogenous serotonin release of a recently developed, selective 5-HT1A receptor PET radiopharmaceutical, the agonist [18F]F13640 (a.k.a. befiradol or NLX-112). Materials and methods: Four cats each underwent three PET scans with [18F]F13640, i.e., a control PET scan of 90 min, a PET scan preceded 30 min before by an intravenous injection 1 mg/kg of d-fenfluramine, a serotonin releaser (blocking challenge), and a PET scan comprising the intravenous injection of 1 mg/kg of d-fenfluramine 30 min after the radiotracer injection (displacement challenge). Data were analyzed with regions of interest and voxel-based approaches. A lp-ntPET model approach was implemented to determine the dynamic of serotonin release during the challenge study. Results: D-fenfluramine pretreatment elicited a massive inhibition of [18F]F13640 labeling in regions known to express 5-HT1A receptors, e.g., raphe nuclei, hippocampus, thalamus, anterior cingulate cortex, caudate putamen, occipital, frontal and parietal cortices, and gray matter of cerebellum. Administration of d-fenfluramine during PET acquisition indicates changes in occupancy from 10% (thalamus) to 31% (gray matter of cerebellum) even though the dissociation rate of [18F]F13640 over the 90 min acquisition time was modest. The lp-ntPET simulation succeeded in differentiating the control and challenge conditions. Conclusion: The present findings demonstrate that labeling of 5-HT1A receptors with [18F]F13640 is sensitive to serotonin concentration fluctuations in vivo. Although the data underline the need to perform longer PET scan to ensure accurate measure of displacement, they support clinical development of [18F]F13640 as a tool to explore experimental paradigms involving physiological or pathological (neurological or neuropsychiatric pathologies) fluctuations of extracellular serotonin.

5-HT_FAsTR: a versatile, label-free, high-throughput, fluorescence-based microplate assay to quantify serotonin transport and release

A Novel Application of LAPS for the Determination of Serotonin

A Label-Free Fluorescence Aptamer Sensor for Point-of-Care Serotonin Detection

Fluorescent non-canonical amino acid provides insight into the human serotonin transporter

Development of a Highly Specific Fluorescent Probe based on Thiol‐ene Click Nucleophilic Cascade Reactions for Delving into the Action Mechanism of Serotonin in Depression

Determining Ligand and Ion-Induced Conformational Changes in Serotonin Transporter with Its Fluorescent Substrates

Directed Evolution of a Selective and Sensitive Serotonin Sensor via Machine Learning

Fluorescence lifetime imaging of sDarken as a tool for the evaluation of serotonin levels

A reusable neurotransmitter aptasensor for the sensitive detection of serotonin

Serotonin GPCR-based biosensing modalities in yeast

[18F]F13640, a 5-HT1A Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations

A simple, efficient and rapid HPLC–UV method for the detection of 5-HT in RIN-14B cell extract and cell culture medium

A genetically encoded sensor for measuring serotonin dynamics

An Efficient and Label-Free LC-MS/MS Method for Assessing Drug's Activity at Dopamine and Serotonin Transporters Using Transporter-Transfected HEK293T Cells.

Feasibility of Using Serum, Plasma, and Platelet 5-hydroxytryptamine as Peripheral Biomarker for the Depression Diagnosis and Response Evaluation to Antidepressants: Animal Experimental Study

Turn-on Fluorescent Aptasensing for the Determination of Serotonin Via Target-Induced Knot Displacement at Corona.

Fluorine-18 Labeled Diphenyl Sulfide Derivatives for Imaging Serotonin Transporter (SERT) in the Brain

Serotonin G Protein-Coupled Receptor-Based Biosensing Modalities in Yeast

The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter

A luminescent sensor for investigating serotonin metabolism in neuroendocrine cancer

Label‐Free Electrochemical Aptasensor for the Determination of Serotonin